The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.538%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.75
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-On Investment into Existing Royalty Partner

20 Apr 2022 07:00

RNS Number : 6692I
Duke Royalty Limited
20 April 2022
 

20 April 2022

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

Follow-On Investment into Existing Royalty Partner

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce a follow-on investment of £2.3 million into existing royalty partner Tristone Healthcare Limited ("Tristone") to fund its latest acquisition as well as provide funding for capital expenditure.

Tristone provides specialist residential and domiciliary care in two end markets: i) high acuity adults with severe mental, physical or learning disabilities; and ii) care leavers, aged between 16 and 19, who are transitioning out of social care and into independent living.

Highlights:

 

· Duke's funds will facilitate Tristone's acquisition of Beyond Limits (Plymouth) Limited ("Beyond Limits"), which operates specialist care homes predominantly in the Southwest of England, providing long-term residential care to people with learning disabilities, mental health issues and other support needs 

· The financing increases Duke's total investment into Tristone to £14.4 million. The investment terms are the same as Duke's previous follow-on investment into Tristone, including a starting yield of 13.5% and the normal +/- 6% annual revenue adjustment factor

· Beyond Limits represents Tristone's second acquisition supported by Duke, in line with Tristone's stated buy & build strategy

· Duke will also be providing £300k of funds to initiate the refurbishment of premises that will be used as an extension of Pro Care Wales, one of Tristone's existing businesses, which is seeing healthy demand from local authorities to place additional service users

· Tristone has a deep understanding of the demands of social care and has extensive experience of investing in businesses of this nature, having supported a number of different care businesses since formation in 2015.

 

Neil Johnson, CEO of Duke Royalty, said:

"It's pleasing to see Tristone executing on its 'buy-and-build' strategy using our capital. Once again, the company has sourced and acquired a target that shares both an existing culture of providing the highest quality of care, with the opportunity for further growth and betterment.

"Beyond Limits will be a great addition to the existing Tristone community. Supporting the acquisitions of our royalty partners allows them to grow and diversify which benefits both themselves and Duke."

Further information regarding Beyond Limits

Beyond Limits, established in 2012, is a successful provider of support to people with learning disabilities, mental health issues and other support needs. Beyond Limits was founded by Doreen Kelly who was formerly a mental health nurse and has been involved in the voluntary and independent sector since 1986. Beyond Limits is a Care Quality Commission (CQC) registered service provider and has achieved an overall rating of 'Outstanding'. The service specialises in providing care for adults with learning disabilities, autistic spectrum disorders, mental illness, or physical disabilities. The support is provided to Service Users in their own homes, or through a portfolio of residential homes primarily in Devon, Cornwall, and Somerset. The service currently supports 26 individuals from the age of 18 plus, with some people requiring support with personal care.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of our website: www.dukeroyalty.com/partners

 

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited
Neil Johnson / Charles Cannon Brookes / Hugo Evans
 
+44 (0) 1481 730 613
Cenkos Securities plc 
(Nominated Adviser
and Joint Broker)
 
Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson
+44 (0) 207 397 8900
Canaccord Genuity
(Joint Broker)
 
Adam James / Georgina McCooke
+44 (0) 207 523 8000
SEC Newgate (PR)
Elisabeth Cowell/ Richard Bicknell/ Max Richardson
+44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTILMMTMTBBTPT
Date   Source Headline
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results
9th Jun 20177:00 amRNSRoyalty Partner Operational Update
6th Apr 20177:00 amRNSInaugural royalty financing agreement
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 20172:55 pmRNSHolding(s) in Company
23rd Mar 20175:00 pmRNSRe-Admission and First Day of Dealings
22nd Mar 20173:45 pmRNSSch 1 Update - Duke Royalty Limited
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.